Regulation of hemostasis by the sympathetic nervous system: Any contribution to coronary artery disease?

HeartDrug

Volumn 4, Issue 3, 2004, Pages 123-130

  Preckel, Daniel ^a   Von Känel, Roland ^a,b  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Adrenergic activation; Hemostasis; Physical exercise; Stress; Sympathetic nervous system

Indexed keywords

ADRENERGIC RECEPTOR; CATECHOLAMINE; FIBRINOGEN;

ACUTE DISEASE; ADRENERGIC ACTIVITY; ADRENERGIC SYSTEM; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD CLOTTING; CARDIOVASCULAR RISK; CHRONICITY; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; EXERCISE; FIBRINOLYSIS; HEART INNERVATION; HEMOSTASIS; HUMAN; HYPERACTIVITY; HYPERCOAGULABILITY; MENTAL STRESS; NEUROPHYSIOLOGY; PATHOPHYSIOLOGY; PHYSICAL STRESS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SYMPATHETIC TONE; THROMBOCYTE ACTIVATION;

EID: 4344620712     PISSN: 14229528     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078415     Document Type: Review

References (72)

1. Cannon WB, Mendenhall WL: Factors affecting the coagulation time of blood. IV. The hastening of coagulation in pain and emotional excitement. Am J Physiol 1914;34:251-261.
2. Folsom AR: 'New' risk factors for atherosclerotic diseases. Exp Gerontol 1999;34:483-490.
3. Colman RW, Clowes AW, George JN, Hirsh J, Marder VJ (eds): Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Philadelphia, Williams & Wilkins, 2001.
4. Koenig W: Haemostatic risk factors for cardiovascular diseases. Eur Heart J 1998;19(suppl C):C39-C43.
5. Folsom AR: Hemostatic risk factors for atherothrombotic disease: An epidemiologic view. Thromb Haemost 2001;86:366-373.
6. Ruberg FL, Loscalzo J: Prothrombotic determinants of coronary atherothrombosis. Vasc Med 2002;7:289-299.
7. Falk E, Fernandez-Ortiz A: Role of thrombosis in atherosclerosis and its complications. Am J Cardiol 1995;75:3B-11B.
8. Moreno PR, Bernardi VH, Lopez-Cuellar J, Murcia AM, Palacios IF, Gold HK, Mehran R, Sharma SK, Nemerson Y, Fuster V, Fallon JT: Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation 1994;94:3090-3097.
9. Pitsilos S, Hunt J, Mohler ER, Prabhakar AM, Poncz M, Dawicki J, Khalapyan TZ, Wolfe ML, Fairman R, Mitchell M, Carpenter J, Golden MA, Cines DB, Sachais BS: Platelet factor 4 localization in carotid atherosclerotic plaques: Correlation with clinical parameters. Thromb Haemost 2003;90:1112-1120.
10. Smith EB, Keen GA, Grant A, Stirk C: Fate of fibrinogen in human arterial intima. Arteriosclerosis 1990;10:263-275.
11. Koenig W: Fibrin(ogen) in cardiovascular disease: An update. Thromb Haemost 2003;89:601-609.
12. Kohler HP, Grant PJ: Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 2000;342:1792-1801.
13. Danesh J, Whincup P, Walker M, Lennon L, Thomsom A, Appleby P, Rumley A, Lowe G: Fibrin D-dimer and coronary heart disease: Prospective study and meta-analysis. Circulation 2001;103:2323-2327.
14. Haverkate F: Levels of haemostatic factors, arteriosclerosis and cardiovascular disease. Vascul Pharmacol 2002;39:109-112.
15. Thomas DP, Roberts HR: Hypercoagulability in venous and arterial thrombosis. Ann Intern Med 1997;126:638-644.
16. Tripodi A: Levels of coagulation factors and venous thromboembolism. Haematologica 2003;88:705-711.
17. Cushman M, Folsom AR, Wang L, Aleksic N, Rosamond WD, Tracy RP, Heckbert SR: Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood 2003;101:1243-1248.
18. von den Velden R: Zur kreislaufanaleptischen und telehämostyptischen Wirkung des Nebennierenextraktes. Münch Med Wochenschr 1911;58:184-188.
19. Vosburgh CH, Richards AN: An experimental study of the sugar content and extra vascular coagulation of the blood after administration of adrenalin. Am J Physiol 1903;9:35-51.
20. von Känel R, Dimsdale JE: Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol 2000;65:357-369.
21. Wallen NH, Goodall AH, Li N, Hjemdahl P: Activation of haemostasis by exercise, mental stress and adrenaline: Effects on platelet sensitivity to thrombin and thrombin generation. Clin Sci (Lond) 1999;97:27-35.
22. van der Poll T, Levi M, Dentener M, Jansen PM, Coyle SM, Braxton CC, Buurman WA, Hack CE, ten Cate JW, Lowry SF: Epinephrine exerts anticoagulant effects during human endotoxemia. J Exp Med 1997;185:1143-1148.
23. Mannucci PM, Aberg M, Nilsson IM, Robertson B: Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. Br J Haematol 1975;30:81-93.
24. von Känel R, Dimsdale JE, Adler KA, Dillon E, Perez CJ, Mills PJ: Effects of nonspecific beta-adrenergic stimulation and blockade on blood coagulation in hypertension. J Appl Physiol 2003;94:1455-1459.
25. Lande K, Kjeldsen SE, Os I, Westheim A, Hjermann I, Eide I, Gjesdal K: Increased platelet and vascular smooth muscle reactivity to lowdose adrenaline infusion in mild essential hypertension. J Hypertens 1988;6:219-225.
26. Hemingway H, Marmot M: Evidence based cardiology: Psychosocial factors in the aetiology and prognosis of coronary heart disease. Systematic review of prospective cohort studies. BMJ 1999;318:1460-1467.
27. Rozanski A, Blumenthal JA, Kaplan J: Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999;99:2192-2217.
28. Krantz DS, McCeney MK: Effects of psychological and social factors on organic disease: A critical assessment of research on coronary heart disease. Annu Rev Psychol 2002;53:341-369.
29. Black PH, Garbutt LD: Stress, inflammation and cardiovascular disease. J Psychosom Res 2002;52:1-23.
30. von Känel R, Mills PJ, Fainman C, Dimsdale JE: Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: A biobehavioral pathway to coronary artery disease? Psychosom Med 2001;63:531-544.
31. von Känel R, Dimsdale JE: Fibrin D-dimer: A marker of psychosocial distress and its implications for research in stress-related coronary artery disease. Clin Cardiol 2003;26:164-168.
32. Jern C, Eriksson E, Tengborn L, Risberg B, Wadenvik H, Jern S: Changes of plasma coagulation and fibrinolysis in response to mental stress. Thromb Haemost 1989;62:767-771.
33. Kario K, Matsuo T, Kobayashi H, Yamamoto K, Shimada K: Earthquake-induced potentiation of acute risk factors in hypertensive elderly patients: Possible triggering of cardiovascular events after a major earthquake. J Am Coll Cardiol 1997;29:926-933.
34. von Känel R, Mills PJ, Ziegler MG, Dimsdale JE: Effect of beta2-adrenergic receptor functioning and increased norepinephrine on the hypercoagulable state with mental stress. Am Heart J 2002;144:68-72.
35. Tomoda F, Takata M, Kagitani S, Kinuno H, Yasumoto K, Tomita S, Inoue H: Different platelet aggregability during mental stress in two stages of essential hypertension. Am J Hypertens 1999;12:1063-1070.
36. Palermo A, Bertalero P, Pizza N, Amelotti R, Libretti A: Decreased fibrinolytic response to adrenergic stimulation in hypertensive patients. J Hypertens Suppl 1989;7:S162-S163.
37. Grignani G, Pacchiarini L, Zucchella M, Tacconi F, Canevari A, Soffiantino F, Tavazzi L: Effect of mental stress on platelet function in normal subjects and in patients with coronary artery disease. Haemostasis 1992;22:138-146.
38. Canevari A, Tacconi F, Zucchella M, Pacchiarini L, Soffiantino F, Grignani G: Antithrombin III biological activity and emotional stress in patients with coronary artery disease. Haematologica 1992;77:180-182.
39. von Känel R, Dimsdale JE, Ziegler MG, Mills PJ, Patterson TL, Lee SK, Grant I: Effect of acute psychological stress on the hypercoagulable state in subjects (spousal caregivers of patients with Alzheimer's disease) with coronary or cerebrovascular disease and/or systemic hypertension. Am J Cardiol 2001;87:1405-1408.
40. Steptoe A, Kunz-Ebrecht S, Owen N, Feldmann PJ, Rumley A, Lowe GD, Marmot M: Influence of socioeconomic status and job control on plasma fibrinogen responses to acute mental stress. Psychosom Med 2003;65:137-144.
41. von Känel R, Dimsdale JE, Adler KA, Patterson TL, Mills PJ, Grant I: Effects of depressive symptoms and anxiety on hemostatic responses to acute mental stress and recovery in the elderly. Psychiatry Res, in press.
42. Dimsdale JE, Ziegler MC: What do plasma and urinary measures of catecholamines tell us about human response to stressors? Circulation 1991;83(4 suppl):II36-II42.
43. Ishizaki M, Tsuritani I, Noborisaka Y, Yamada Y, Tabata M, Nakagawa H: Relationship between job stress and plasma fibrinolytic activity in male Japanese workers. Int Arch Occup Environ Health 1996;68:315-320.
44. Vrijkotte TG, van Doornen LJ, Geus EJ: Work stress and metabolic and hemostatic risk factors. Psychosom Med 1999;61:796-805.
45. von Känel R, Dimsdale JE, Adler KA, Patterson TL, Mills PJ, Grant I: Exaggerated plasma fibrin turnover (D-dimer) in Alzheimer caregivers as compared to non-caregiving controls. Gerontology, in press.
46. von Känel R, Dimsdale JE, Patterson TL, Grant I: Association of negative life event stress with coagulation activity in elderly Alzheimer caregivers. Psychosom Med 2003;65:145-150.
47. von Känel R, Dimsdale JE, Patterson TL, Grant I: Acute procoagulant stress response as a dynamic measure of allostatic load in Alzheimer caregivers. Ann Behav Med 2003;26:42-48.
48. von Känel R, Bardwell WA, Berry CC, Dimsdale JE: Independent contribution of psychological factors to fibrin turnover in subjects with sleep apnoea and/or systemic hypertension. Clin Sci (Lond) 2002;103:331-337.
49. Cole SR, Kawachi I, Sesso HD, Paffenbarger RS, Lee IM: Sense of exhaustion and coronary heart disease among college alumni. Am J Cardiol 1999;84:1401-1405.
50. Appels A, Mulder P: Excess fatigue as a precursor of myocardial infarction. Eur Heart J 1988;9:758-764.
51. Kop WJ, Appels AP, Mendes de Leon CF, de Swart HB, Bar FW: Vital exhaustion predicts new cardiac events after successful coronary angioplasty. Psychosom Med 1994;56:281-287.
52. Raikkonen K, Lassila R, Keltikangas-Jarvinen L, Hautanen A: Association of chronic stress with plasminogen activator inhibitor-1 in healthy middle-aged men. Arterioscler Thromb Vasc Biol 1996;16:363-367.
53. Kop WJ, Hamulyak K, Pernot C, Appels A: Relationship of blood coagulation and fibrinolysis to vital exhaustion. Psychosom Med 1998;60:352-358.
54. van Diest R, Hamulyak K, Kop WJ, van Zandvoort C, Appels A: Diurnal variations in coagulation and fibrinolysis in vital exhaustion. Psychosom Med 2002;64:787-792.
55. von Känel R, Maly FE, Frey K, Fischer JE: Contribution of the type 1 plasminogen activator inhibitor 4G/5G gene polymorphism to impaired fibrinolysis in vital exhaustion. Ital Heart J 2003;4:791-796.
56. Yamamoto K, Takeshita K, Shimokawa T, Yi H, Isobe K, Loskutoff DJ, Saito H: Plasminogen activator inhibitor-1 is a major stress regulated gene: Implications for stress induced thrombosis in aged individuals. Proc Natl Acad Sci USA 2002;99:890-895.
57. Venugopal B, Sharon R, Abramovitz R, Khasin A, Miskin R: Plasminogen activator inhibitor-1 in cardiovascular cells: Rapid induction after injecting mice with kainate or adrenergic agents. Cardiovasc Res 2001;49:476-483.
58. von Känel R, Kudielka BM, Abd-El-Razik A, Gander M, Frey K, Fischer JE: Relationship between overnight neuroendocrine activity and morning hemostasis in working men. Clin Sci (Lond), in press.
59. von Känel R, Dimsdale JE: Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease. Chest 2003;124:1956-1967.
60. Eisensehr I, Ehrenberg BL, Noachtar S, Korbett K, Byrne A, McAuley A, Palabrica T: Platelet activation, epinephrine, and blood pressure in obstructive sleep apnea syndrome. Neurology 1998;51:188-195.
61. Wessendorf TE, Thilmann AF, Wang YM, Schreiber A, Konietzko N, Teschler H: Fibrinogen levels and obstructive sleep apnea in ischemic stroke. Am J Respir Crit Care Med 2000;162:2039-2042.
62. Maron BJ, Poliac LC, Roberts WO: Risk for sudden cardiac death associated with marathon running. J Am Coll Cardiol 1996;28:428-431.
63. Albert CM, Mittleman MA, Chae CU, Lee IM, Hennekens CH, Manson JE: Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med 2000;343:1355-1361.
64. Ciampricotti R, el Gamal MI, Bonnier JJ, Relik TH: Myocardial infarction and sudden death after sport: Acute coronary angiographic findings. Cathet Cardiovasc Diagn 1989;17:193-197.
65. Maron BJ: Sudden death in young athletes. N Engl J Med 2003;349:1064-1075.
66. Virmani R, Burke AP, Farb A: Sudden cardiac death. Cardiovasc Pathol 2001;10:211-218.
67. Smith JE: Effects of strenuous exercise on haemostasis. Br J Sports Med 2003;37:433-435.
68. el-Sayed MS: Effects of exercise on blood coagulation, fibrinolysis and platelet aggregation. Sports Med 1996;22:282-298.
69. Siegel AJ, Stec JJ, Lipinska I, Van Cott EM, Lewandrowski KB, Ridker PM, Tofler GH: Effect of marathon running on inflammatory and hemostatic markers. Am J Cardiol 2001;88:918-920.
70. Smith DT, Hoetzer GL, Greiner JJ, Stauffer BL, DeSouza CA: Effects of ageing and regular aerobic exercise on endothelial fibrinolytic capacity in humans. J Physiol 2003;546:289-298.
71. Gaab J, Blattler N, Menzi T, Pabst B, Stoyer S, Ehlert U: Randomized controlled evaluation of the effects of cognitive-behavioral stress management on cortisol responses to acute stress in healthy subjects. Psychoneuroendocrinology 2003;28:767-779.
72. Camacho A, Dimsdale JE: Platelets and psychiatry: Lessons learned from old and new studies. Psychosom Med 2000;62:326-336.